AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 25 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01370-07v1
52/5/1871    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakeya, H.
Right arrow Articles by Kohno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakeya, H.
Right arrow Articles by Kohno, S.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01370-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Efficacy of SPK-843, a Novel Polyene Antifungal in a Murine Model of Systemic Cryptococcosis

Hiroshi Kakeya*, Yoshitsugu Miyazaki, Hisato Senda, Tsutomu Kobayashi, Masafumi Seki, Koichi Izumikawa, Yoshihiro Yamamoto, Kazunori Yanagihara, Takayoshi Tashiro, and Shigeru Kohno

Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Bioactive Molecules, National Institute of Infectious Disease, Japan; Kaken Pharmaceutical Co., Ltd., Kyoto, Japan

* To whom correspondence should be addressed. Email: kakeya{at}nagasaki-u.ac.jp.


   Abstract

SPK-843, a new polyene antifungal, possessed efficacy against a murine systemic infection caused by Cryptococcus neoformans. The administration of 4.0 mg/kg SPK-843 revealed better survival prolongation and fungal reduction than those observed with the administration of 0.7 mg/kg amphotericin B and 80 mg/kg fluconazole (p < 0.001) without histopathological renal changes.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.